Related Experiment Video
Updated: Aug 13, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 11, 2013
Host defense impairments that may lead to respiratory infections
1Pulmonary Section, Yale University School of Medicine, New Haven, Connecticut.
Abstract:
Host defense mechanisms spaced along the respiratory tree and in the alveolar spaces effectively remove or contend with micro-organisms that enter the airways, so serious lung infections occur rarely in healthy people. Special circumstances, such as virgin exposure to a virulent microbe or a large innoculum of a pathogen, can result in illness, but usually routine surveillance host defenses are protective and suffice to keep colonizing airway flora in check. When pneumonia develops or recurrent sinopulmonary infection exists, however, some element of the normal defense apparatus may have failed or is inadequate. This review highlights several components of the apparatus, that is immunoglobulins IgG and IgA and the interaction of alveolar macrophages and lymphocytes, and examines deficiencies in their function that may result in infection. Along the conducting airways, poor mucociliary clearance and/or deficiencies in certain IgG subclass antibodies or destruction of IgA may predispose to sinopulmonary infections; these may be a manifestation of a hereditary disease. In pneumonia the alveolar macrophage is positioned as the central cell which must respond in several directions. This scavenger phagocyte first intercepts the microbe and either can kill or contain it or must call in some other phagocytic cell or inflammatory mediator(s) for assistance. Opsonic antibodies (IgG) and other nonimmune opsonins (complement and surfactant or fibronectin fragments) facilitate phagocytosis, but an absence of antibody may permit infection to develop with encapsulated bacteria (pneumococcus). Insufficient bone marrow reserves of PMNs or a paucity of chemotactic factors to attract them into the alveoli is a situation that may permit gram-negative bacilli and fungal organisms to flourish. Inability of immune T-lymphocytes to energize macrophages, through soluble cellular mediators that provide cell-mediated immunity and activation, makes containment of certain intracellular microbes impossible for these phagocytes (Legionella or mycobacteria). Likewise, concomitant infection of macrophages with viruses (human immunodeficiency virus, and cytomegalovirus or herpes viruses) plus an excessive T-lymphocyte suppressor cell influence may make P. carinii and common bacterial and fungal organisms difficult to contain in the lungs of AIDS patients. Consideration about what the lung host deficiency might be can make therapy more specific through immunization to develop special antibodies, replacement of certain immunoglobulins (IgG subclasses), or selective administration of cell mediators (gamma-interferon or interleukins).
Insights
Host defense failures in the respiratory system, including immunoglobulin deficiencies and impaired macrophage function, can lead to serious lung infections like pneumonia. Understanding these immune gaps can guide targeted therapies for better outcomes.
Area of Science:
- Immunology and Respiratory Medicine
- Host Defense Mechanisms
- Infectious Diseases
Background:
- Healthy individuals possess robust respiratory defenses against microbial invasion.
- Impaired host defenses, including immunoglobulin deficiencies and cellular immune dysfunction, can lead to recurrent sinopulmonary infections and pneumonia.
- Understanding these deficiencies is crucial for diagnosing and managing lung infections.
Purpose of the Study:
- To review key components of respiratory host defense mechanisms.
- To examine how deficiencies in immunoglobulins (IgG, IgA), alveolar macrophages, and lymphocytes contribute to lung infections.
- To explore how identifying specific host deficiencies can inform targeted therapeutic strategies.
Main Methods:
- Review of existing literature on respiratory host defense mechanisms.
- Analysis of the roles of immunoglobulins (IgG, IgA), alveolar macrophages, and lymphocytes in combating respiratory pathogens.
- Examination of how functional deficits in these components predispose to various lung infections.
Main Results:
- Deficiencies in mucociliary clearance, IgG subclasses, or IgA can lead to sinopulmonary infections.
- Alveolar macrophages are central to pathogen clearance, with impaired phagocytosis or intracellular killing capacity increasing infection risk.
- Defects in T-lymphocyte-mediated immunity and viral coinfections (e.g., HIV) can compromise the containment of opportunistic pathogens like P. carinii.
Conclusions:
- Specific host defense deficiencies, including antibody and cellular immune defects, are implicated in the pathogenesis of lung infections.
- Therapeutic approaches can be tailored by identifying the specific immune deficit.
- Potential therapies include immunization, immunoglobulin replacement, and administration of cell mediators like gamma-interferon.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Other Pulmonary Disorders
Microbiota of the Respiratory Tract
Respiratory Syncytial Virus Disease

